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Calcium’s role as nuanced modulator of cellular physiology in
the brain
Hilaree N Frazier, Shaniya Maimaiti, Katy L Anderson, Lawrence D Brewer, John C Gant,
Nada M Porter, and Olivier Thibault
UKMC, MS-313, Department of Pharmacology and Nutritional Sciences, University of Kentucky
Medical Center, 800 Rose Street, Lexington, KY 40536
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Abstract

Author Manuscript

Neuroscientists studying normal brain aging, spinal cord injury, Alzheimer’s disease (AD) and
other neurodegenerative diseases have focused considerable effort on carefully characterizing
intracellular perturbations in calcium dynamics or levels. At the cellular level, calcium is known
for controlling life and death and orchestrating most events in between. For many years,
intracellular calcium has been recognized as an essential ion associated with nearly all cellular
functions from cell growth to degeneration. Often the emphasis is on the negative impact of
calcium dysregulation and the typical worse-case-scenario leading inevitably to cell death.
However, even high amplitude calcium transients, when executed acutely can alter neuronal
communication and synaptic strength in positive ways, without necessarily killing neurons. Here,
we focus on the evidence that calcium has a subtle and distinctive role in shaping and controlling
synaptic events that underpin neuronal communication and that these subtle changes in aging or
AD may contribute to cognitive decline. We emphasize that calcium imaging in dendritic
components is ultimately necessary to directly test for the presence of age- or disease-associated
alterations during periods of synaptic activation.
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The role of calcium in neurodegenerative disorders has evolved significantly since early
experiments showing hippocampal cell death in areas CA3 and CA1 in response to sustained
synaptic activation of the perforant path in vivo [1]. These, and similar early experiments
identified mechanisms of neuronal death reminiscent of calcium-induced necrosis,
accompanied with blebbing of dendrites, retraction of processes, swelling of the soma and,
ultimately, cellular death [2; 3; 4]. Framed in the context of a lengthy exposure to
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glutamatergic neurotransmitters, these necrosis-associated events provided robust evidence
that calcium could be a perpetuator of cell death. However, a combination of advanced
reporter technologies and improved resolution in calcium imaging techniques have provided
more recent evidence that calcium can be very subtle and localized to small cellular domains
in response to subthreshold or suprathreshold transient synaptic depolarizations.

Author Manuscript
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In the field of neuronal calcium dynamics, perhaps understandably, there appears to be a
subjective preoccupation with the harmful effects of calcium dysregulation. However, a brief
survey of the literature shows this is not well supported by the extent of the overall research
in this area. Here we attempted to translate this idea in graphical form using data on
published manuscripts across several fields. Examination of the literature between 1970 and
2015 (Fig. 1) shows the number of published manuscripts linking “brain” and “calcium” to a
variety of other neurological changes in brain physiology, and pathology over the 45-year
span. As a proportion of the total number of published manuscripts in all fields of science,
the number of published work on brain calcium and physiology increased nearly 10-fold
between the years 1975 and 2000 (Fig 1A). It is interesting to note that whether looking at
aging (Fig. 1B) or AD reports (Fig. 1C), physiological associations between brain and
calcium represent the largest proportion of the overall scientific published work, while cell
death, and pathology associated processes encompass a smaller body of work. We then
determined what proportion of the manuscripts in the following categories: “calcium and
brain” or “calcium and brain aging” or “calcium and brain and AD“, focused on either
physiology, cell death of pathology. The data obtained every 5 years were then averaged
across the last 30 years (Fig.1D). While scientific output steadily increased over that period
(e.g., calcium and brain return 826 manuscripts in 1985, and 2032 manuscripts in 2015), the
proportion of physiologically-related manuscripts within each of the categories has remained
greater (~23 % to 55%, Fig 1D) compared to papers associating calcium in the brain with
pathology or cell death (~3% to 20%). A caveat should be added that we did not attempt to
identify repeat manuscripts in the dataset (i.e., papers studying both physiology and
pathology in relationship to calcium in the brain), thus, the numbers we report may be
slightly inflated. Nevertheless, together, these data suggest that more studies have been
published on associations between calcium and its physiological consequences rather than
on how calcium influences cell death or pathophysiology.
Here we briefly review how age- and neurodegeneration-related changes in oxidation/
inflammation and certain hormones influence calcium dysregulation and impact cellular
physiology. We also discuss the importance of focusing on the more subtle and localized
calcium microdomains in neurons to better elucidate the impact of changes in calcium
signaling in aging or in disease.

Author Manuscript

2. Calcium dysregulation in Alzheimer’s disease (AD) and AD models
Early studies by several pioneering groups identified cellular calcium dysregulation as a
major factor underlying functional alterations in aging tissues. These observations
contributed to the formulation of the calcium hypothesis of brain aging and AD [5; 6]. This
work was followed by studies in human cortical cells showing that the β-amyloid peptide
increases calcium levels at rest and in response to excitatory neurotransmitter release,
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resulting in compromised neuronal cell health [7]. Later studies in neurons harboring
presenilin-1 (PS-1) mutations, a key player in Aβ formation, helped identify several
endoplasmic reticulum (ER) calcium handling proteins as targets of the genetic mutation [8].
Even human fibroblast and lymphoblasts display robust evidence of calcium dysregulation
in AD [9; 10; 11], suggesting the dysregulation may be “system-wide” rather than just CNScentered. Whether calcium dysregulation is a crucial initiator of the neuronal pathology, or a
downstream event has been an open-ended question. Some studies have placed abnormal
Ca2+ elevations downstream of PS-1 mutations [12; 13; 14]. On the other hand, ryanodine
receptors and IP3 receptors have been identified as perpetrators of calcium dysregulation
[15; 16; 17; 18; 19; 20] and reducing IP3R expression in 3×Tg mice attenuates Ca2+
signaling, Aβ production and Tau hyperphosphorylation [20]. PS1 and PS2 mutations have
also been found to directly target ER function, reducing ER calcium leaks, and overloading
the ER with excess calcium [21; 22; 23]. Loss-of-function PS1 mutations are also associated
with disturbed calcium-dependent lysosomal and autophagic pathways [24; 25].
Interestingly, recent studies in animal models of AD using multiphoton calcium imaging
techniques demonstrate that calcium overload may not be generalized to all neurons and
could be dependent on proximity to a Aβ plaque [26; 27]; however, another study finds no
association between distance from a plaque and neuronal calcium dysregulation [28]. In
addition, neurofibrillary tangles do not appear to alter calcium levels or cellular excitability
in the visual and somatosensory cortex [29], nor do they appear to alter calcium homeostasis
in the cortex of animals displaying significant synapse loss [30].

Author Manuscript

Our understanding of the relationship between calcium dysregulation and AD in the brain
still lacks clarity, and calcium dysregulation may also act upstream of AD pathology,
whereby elevations in Ca2+ can increase production of oligomeric Aβ peptides [31]. As
such, stabilizing ER calcium with dantrolene, a ryanodine receptor antagonist, restores
normal synaptic function and plasticity and reduces amyloid load in the brains of 3×Tg AD
mice [32] and knock-in FAD mice [33].

3. Oxidative stress, inflammation, and calcium

Author Manuscript

Calcium dysregulation tied to oxidative stress or inflammation in neuronal cells can have
deleterious and long-lasting consequences resulting in calcium overload which may increase
neuronal vulnerability under pathological conditions including AD [13; 19; 34; 35; 36].
Indeed, sustained NMDA receptor activation or even reduced NMDA receptor inactivation
can increase calcium elevations (immediate or delayed) which in turn, can produce reactive
oxygen species (ROS) as a result of increased mitochondrial energy demands [37]. Still, it is
not clear that the increase in ROS seen around the time of neuronal cell death with calcium
overload is actually the cause of death or the consequence of the depolarized mitochondria
[37].
ROS production in response to Aβ peptides or other challenges in the brain [38; 39] is well
known to alter protein function [40; 41], and recently has also been shown to directly alter
calcium channels [42; 43]. Still, the threshold (if there is one) to induce these devastating
signaling pathways and the relationship to Ca2+ levels in vivo has been as difficult to
identify as the targets of the oxidative stressors in the brain [44]. The poor clinical
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therapeutic translation seen in AD patients taking anti-oxidative therapies may be due to the
fact that the precise targets are still unknown [45].
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Brain inflammation, mediated by numerous cytokines (TNF-alpha, AIF, JNK) is common
across brain aging and AD studies [46; 47; 48; 49] and has been linked to calcium
dysregulation. This calcium dysregulation, in turn has been shown to have consequences for
synaptic plasticity [50; 51]. Calcium dysregulation alters the balance between LTP and LTD
presumably through changes in the activation of select phosphatases and kinases [52; 53; 54;
55; 56]. However, this relationship has never been tested in vivo or with sufficient spatial or
temporal resolution to address calcium dynamics in microdomains near postsynaptic
densities at the exact sites of synaptic communication. Given the complex structure of
postsynaptic densities in dendritic spines which includes ion channels, anchoring proteins,
kinases and phosphatases [57; 58; 59; 60; 61], this is a particularly important challenge that
can only be surmounted with higher resolution microscopy that allows for measures of very
controlled calcium rises during synaptic activation. Studies using tissue homogenates may
be missing the impact of inflammation on calcium microdomains and the resulting synaptic
processes.
At least one aspect of the association between oxidant/ inflammatory stressors and calcium
dysregulation that has not received enough attention is whether different thresholds of
dysregulation result in select activation of downstream pathways and/or different outcomes
[7; 62; 63]. For example, it is not clear whether several repeated calcium events of smaller
amplitudes (i.e., ministrokes) are as impactful as a single, large amplitude event (i.e., TBI,
stroke). Also unclear, is whether the sensitivity of millisecond calcium cellular events to
oxidant/inflammatory stressors changes across the lifespan.

Author Manuscript

4. The impact of disappearing hormones in the brain of aged animals may
alter calcium homeostasis

Author Manuscript

While oxidative stress and inflammatory processes appear able to hasten calcium
dysregulation with age, several endogenous steroid hormones including vitamin D, estrogen
and insulin seem capable of redressing this dysregulation. We have shown that both vitamin
D and estrogen alter L-VGCC activity and calcium-dependent processes. Vitamin D (1,25
dihydroxvitamin D3) reduces L-VGCC currents probably due to reductions in both Cav1.2
and Cav1.3 expression in primary hippocampal cultures [64]. This reduction in current
activity was also found in CA1 hippocampal neurons and was correlated with an age-related
reduction in the slow afterhyperpolarization (sAHP) which would affect neuronal
excitability [65]. Further, long-term treatment (6 months) of rats beginning at mid-age (12
months) with high vitamin D (10,000 IU cholecalciferol/ Kg rodent diet) showed improved
spatial memory performance on the Morris water maze challenge. Thus, it appears that
interfering with calcium homeostasis through pathways that are capable of increasing
vitamin D receptor activation in the brain, may be a therapeutically meaningful strategy to
preserve cognitive function in age and perhaps AD.
Another hormone, estradiol, has also been shown to modulate L-VGCC expression and
activity in hippocampal neurons and in GnRH related cells [66; 67]. Interestingly, in both of
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these cell types estradiol decreased Cav1.3 expression but not Cav1.2. In addition to
affecting the expression of the L-VGCC subunit estradiol also modulates L-VGCC activity
via a rapid mechanism that results in an increase in calcium influx through L-VGCCs in
neurons and other cell lines [68; 69; 70]. This rapid pathway was proposed to be part of a
neuroprotective pathway; whether it also functions to regulate physiological processes such
as the sAHP is unknown. Nevertheless, the genomic mechanism appears to reduce L-VGCC
activity but the rapid mechanism increases L-VGCC activity. This suggests the possibility
that L-VGCC channel expression and calcium influx are dynamically regulated by estradiol,
and as we and others have previously shown, can be altered in aging [66; 71].

Author Manuscript
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Another recently identified hormone modulator of L-VGCC function in the brain is insulin.
While investigating new mechanisms by which certain antidiabetic compounds can reduce
calcium channel function and the AHP in hippocampal cells [72; 73], we also recently
uncovered the acute and significant actions of insulin on the sAHP [74; 75]. By causing a
significant reduction in the AHP, we predict insulin may be able to enhance cellular
excitability in aging and offset cognitive decline. Indeed, several clinical studies have
provided robust evidence that increasing brain insulin availability through intranasal delivery
of the hormone is able to enhance recall in young subjects [76; 77] or MCI patients [78; 79;
80]. Similarly, we have shown beneficial effects of intranasal insulin on memory recall in
aged animals in the Morris water maze [74]. Surprisingly, both young healthy subjects and
AD patients appear to benefit equally from intranasal insulin. At least in the case of AD, the
intranasal administration is presumed to compensate for the reduced insulin signaling.
Collectively, these results also suggest insulin signaling may be working differently in young
vs aged brains. Irrespective, this work lends further support to continue therapeutic efforts
attempting to maintain insulin signaling in the brain of the elderly population in order to
offset cognitive decline with age or with AD.
In light of these studies, it is tempting to speculate that perhaps vitamin D, estrogen or
insulin signaling are all compromised in the aged brain which may contribute to the
development of dementia, and that increasing the availability of receptors for these
hormones, or the levels of these hormones in the brain could combat cognitive decline in
aging. Further, while it would seem that redressing calcium dyshomeostasis may be a pivotal
approach to facilitate successful brain aging. However, more direct tests of this hypothesis
are required, and investigating how these hormones regulate Ca2+ pathways will provide a
framework on which to build new pharmacological approaches to combat cognitive decline
in aging.

Author Manuscript

5. Cellular calcium transients have a dendritic origin
Nearly 20 years ago, imaging and electrophysiological approaches were used to derive new
information on the complexity of dendritic actions and how neuronal output could be
modified by key ion channels along the dendritic tree [81; 82; 83]. These findings
culminated in the identification of different calcium sources along dendrites, main apical
arbors, spines and shafts [84; 85; 86; 87; 88; 89]. The dendrite is the site for synaptic inputs
where integration of signals from different areas of the brain occurs. As a result of action
potential firing and the subsequent neurotransmitter release, small, albeit significant calcium
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changes are seen in the dendrite and more specifically, the spines of neurons. There, the
more subtle role of calcium in controlling encoding and dendritic excitability through local
calcium transients is now becoming clear, and includes measures in behaving animals [90;
91; 92; 93; 94; 95; 96]. In field CA1, primary hippocampal neurons are able to integrate
signals coming from distal inputs from the entorhinal cortex, and more proximal inputs
emitting from area CA3. At least part of this integration is mediated by newly identified
dendritic calcium plateau potentials in vivo [97]. These short-lived dendritic calcium
transients can help drive complex spike output in the main pyramidal neurons of the
hippocampus by inactivating sodium channels, enhancing LTP [98] and thereby enhancing
firing from coincident inputs in different areas of the brain. This complexity is only
beginning to be elucidated in the dendrites of young or adult animals and this level of spatial
and temporal resolution has not yet been achieved in animal models of aging or AD.

Author Manuscript
Author Manuscript

With the exception of a few additional studies, very little is known about dendritic calcium
transients, their spatial and temporal integration, or about the presence and role of back
propagating action potentials in apical dendrites in models of aging [99; 100]. Furthermore,
these studies did not address changes in cellular cytoarchitecture/ morphology with age, its
potential impact on physiology, nor did they study the impact of age-related changes in
calcium sources on synaptic plasticity or activation. However, more progress along these
lines has been made in animal models of AD. Using genetically-encoded calcium indicators
to monitor calcium in spines of cultured neurons from mutant presenilin mice (M146V),
recent evidence shows the presence of alterations in stromal interaction molecule 2 function
(STIM2; a key regulator of store-operated calcium entry) [101; 102]. In these studies, the
authors suggest that the loss of mushroom spines is mediated by the loss of the stabilizing
effect of STIM2 on spines, and perhaps occurs in response to elevations in ER calcium
levels during aging or in AD [14; 54; 103]. Such studies are helping to identify new
pharmaceutical targets and are highlighting new areas of focus in neuroscience.

Author Manuscript

Work using calcium imaging tools to focus on downstream consequences of calcium
overload in AD models has helped shift the attention away from calcium-mediated cell
death, and instead emphasize calcium-mediated changes in dendritic morphology, cellular
excitability, network activity and plasticity. The first direct in vivo evidence showing that
elevated Ca2+ in cortical dendrites is dependent on the presence of Aβ plaque deposition was
recently identified in an AD animal model. Somewhat surprisingly, it was not the presenilin
mutation, but rather, the APP mutation which was found to be associated with calcium
dysregulation in aged mice [27]. Further, in these APP mutants (17–20 months old),
proximity to the plaque was shown to heighten Ca2+ dysregulation. In another in vivo study
using double transgenic mice, imaging from hippocampal CA1 neuronal somata also
provided evidence of Ca2+ overload, but at much earlier ages (1–2 months) and prior to
plaque deposition. However, a role for soluble amyloid still exists as calcium transients and
hippocampal excitability were elevated upon application of Aβ dimmers [26]. In both
studies, thus it appears that some form of amyloid β may be responsible for inducing
neuronal calcium dysregulation.
Greater spatial and temporal resolutions are currently being implemented in the study of
neuroscience following the discovery of genetically-encoded calcium indicators [104; 105;
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106]. These indicators have the advantage of being fast reporters which can be targeted to
specific cellular compartments like the ER and the mitochondria [107; 108]. Studies
investigating changes in calcium homeostasis using large arrays of cells are also now
providing new in vivo results, but only in a limited number of studies in AD models [27; 29;
109]. High resolution in vivo calcium imaging using pulsed lasers capable of generating
longer wavelengths will provide important information along these lines.

6. New (and old) intricacies of calcium dysregulation with aging

Author Manuscript

Calcium is not always increased in aging and or in AD. Our lab has published evidence of
reduced L-type Ca2+ currents in the aged APP/PS1 mouse [110]. Years ago, Lamour’s lab
showed that calcium dysregulation did not translate well across different strains of rats
[111]. Similarly, the Griffith lab also has reported that depending on L-type calcium channel
subunits present, increases in L-type currents are not always seen with aging in basal
forebrain neurons [112], and are often met with significant increases in calcium buffering
capacity [113; 114; 115]. Recently, it was also shown that while more calcium enters the
plasma membrane of an aged CA1 pyramidal neuron [100; 116], a corresponding increase in
buffering balances this influx up to a point where calcium overload occurs [100]. Of interest,
in a study of normal brain aging, we have identified that aged CA1 pyramidal neurons which
typically display larger Ca2+-dependent afterhyperpolarizations when triggered
postsynaptically, show significantly reduced hyperpolarization (e.g., enhanced
hyperexcitability) compared to young animals, when stimulated synaptically across
physiologically relevant frequencies (3–50 Hz) [117]. It is not yet clear that this form of
hyperpolarization in the hippocampus with age during synaptic activity is dependent on
calcium. It would be surprising if it were not, as stimulation at 7 Hz produces greater
calcium in the soma [118] and dendrites [99; 100] in the aged animal. Given the importance
of synaptic communication, stimulation protocols that approximate physiological patterns of
activity may need to be studied further with aging and in AD-related neurodegeneration.

Author Manuscript

7. Overall
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That changes in intracellular calcium levels occur with age and in Alzheimer’s type
dementia or in other neurodegenerative conditions is not new. As we have known for some
time, calcium can be a sophisticated orchestrator of fine moment-by-moment events, or a
deadly hammer that can overload mitochondria and other calcium buffering systems.
Currently, there is greater appreciation for how calcium is able to shape synaptic events that
underpin neuronal communication. However, in aging and AD, it is unclear the extent to
which dendritic Ca2+ sources are modified. Clearly, associations between an animal’s
behavioral phenotype, electrophysiological characterization across multiple hippocampal
subfields and regions (i.e., dorsal vs. ventral), network activity and sensitivity to hormones,
all need further investigation to understand how calcium sensitive targets are modified in the
context of aging. Perhaps insights from these types of studies will allow us to view calcium
dysregulation in aging and AD as more than just a destructive force, but instead, allow us to
pave the way for novel therapeutic approaches that focus on these more nuanced changes
and their effects on neuronal physiology.
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•

Dysregulated calcium is not only associated with cell death in aging or AD

•

Improved resolution and reporter strategies need implementation in aging
research

•

Dendritic calcium imaging will provide insights into mechanisms of brain
aging

•

Hormonal influence over calcium regulation may be a promising therapeutic
approach
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Figure 1.

Survey of the literature relating to calcium dysregulation in the brain. A PubMed search was
performed with EndNote using the terms “calcium” and “brain” (A) or “calcium” and
“brain” and “aging” (B), or “calcium” and “brain” and “Alzheimer’s disease” (C). The
number of papers containing the combined keywords and an association with “cell death”,
“physiology”, or “pathology” was obtained once every five years between the years 1970
and 2015 and was normalized to the total number of scientific publications that year. We
then restricted the search to the past 30 years and collapsed the data across years and used
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the same search strategy. This time, we normalized the number of papers in cell death,
physiology or pathology to the total number of papers within “calcium” and “brain” or
“calcium” and “brain” and “aging”, or “calcium” and “brain” and “Alzheimer’s disease” is
shown in (D). It is clear that a greater proportion of the literature focusing on calcium in the
brain contains a majority of the work centered on physiological outcomes.
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